Perceptions of Disease State, Treatment Expectations, and Prognosis Among Patients with Myelodysplastic Syndromes

被引：0

作者：

Sekeres, Mikkael A.

Maciejewski, Jaroslaw P. ^{[1
]}

List, Alan F. ^{[2
]}

Steensma, David P. ^{[3
]}

Artz, Andrew ^{[4
]}

Swern, Arlene S. ^{[5
]}

Scribner, Paul ^{[6
]}

Huber, John ^{[6
]}

Stone, Richard

机构：

[1] Cleveland Clin, Taussig Canc Ctr, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA

[3] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA

[4] Univ Chicago Hosp, Chicago, IL 60637 USA

[5] Celgene Corp, Summit, NJ USA

[6] Aplast Anemia & MDS Int Fdn, Rockville, MD USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：704 / 705

页数：2

共 50 条

[21] Influence of comorbidity factors on the prognosis of patients with myelodysplastic syndromes (IVIDS)
Pelz, D.
Nachtkamp, K.
Kuendgen, A.
Strupp, C.
Haas, R.
Germing, U.
LEUKEMIA RESEARCH, 2007, 31 : S30 - S31
[22] The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes
Sarici, Ahmet
Ar, Muhlis Cem
Yokus, Osman
Ongoren, Seniz
Ayer, Mesut
Altindal, Sermin
Koker, Hilal Tan
Kuzu, Omer Faruk
TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (05)
[23] Characterization of disease progression of patients with myelodysplastic syndromes
Koehler, M. -H
Kaivers, J.
Nachtkamp, K.
Haas, R.
Germing, U.
Strapatsas, J.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 45 - 46
[24] Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes
Giraldo, Pilar
Nomdedeu, Benet
Loscertales, Javier
Requena, Carmen
de Paz, Raquel
Tormo, Mar
Navarro, Pilar
Benedit, Patricia
Gasquet, Jose Antonio
CANCER, 2006, 107 (12) : 2807 - 2816
[25] Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes
Montalban-Bravo, Guillermo
Class, Caleb
Ganan-Gomez, Irene
Kanagal-Shamanna, Rashmi
Sasaki, Koji
Richard-Carpentier, Guillaume
Naqvi, Kiran
Wei, Yue
Yang, Hui
Soltysiak, Kelly
Chien, Kelly S.
Bueso-Ramos, Carlos E.
Do, Kim-Anh
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
BLOOD, 2019, 134
[26] Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes
Guillermo Montalban-Bravo
Caleb A. Class
Irene Ganan-Gomez
Rashmi Kanagal-Shamanna
Koji Sasaki
Guillaume Richard-Carpentier
Kiran Naqvi
Yue Wei
Hui Yang
Kelly A. Soltysiak
Kelly Chien
Carlos Bueso-Ramos
Kim-Anh Do
Hagop Kantarjian
Guillermo Garcia-Manero
Leukemia, 2020, 34 : 872 - 881
[27] Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes
Montalban-Bravo, Guillermo
Class, Caleb A.
Ganan-Gomez, Irene
Kanagal-Shamanna, Rashmi
Sasaki, Koji
Richard-Carpentier, Guillaume
Naqvi, Kiran
Wei, Yue
Yang, Hui
Soltysiak, Kelly A.
Chien, Kelly
Bueso-Ramos, Carlos
Do, Kim-Anh
Kantarjian, Hagop
Garcia-Manero, Guillermo
LEUKEMIA, 2020, 34 (03) : 872 - 881
[28] Chromosomal 3 Abnormalities in Myelodysplastic Syndromes: Implications on Prognosis and Response to Treatment
Sallman, David
Al Ali, Najla H.
Padron, Eric
Lancet, Jeffrey E.
List, Alan F.
Komrokji, Rami S.
BLOOD, 2014, 124 (21)
[29] Chromosomal 3 Abnormalities in Myelodysplastic Syndromes: Implications on Prognosis and Response to Treatment
Sallman, David
Al Ali, Najla
Padron, Eric
Lancet, Jeffrey
List, Alan
Komrokji, Rami
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S232 - S232
[30] Characteristics and prognosis of patients with myelodysplastic syndromes admitted to the intensive care unit
Guck, Daniel
Ismail-Sayed, Ibrahim
van de Louw, Andry
LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3057 - 3059

← 1 2 3 4 5 →